Plain-English translation of NCT06917404 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 3 โ Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This research study is testing whether pentosan polysulfate sodium, given as twice-weekly injections under the skin, can safely and effectively reduce knee osteoarthritis pain. Half of the participants will receive the medication, and half will receive a placebo (a harmless saltwater injection that looks identical). The study will track how much pain relief the medication provides compared to placebo over several months.
Many people with knee osteoarthritis don't get enough pain relief from current treatments like physical therapy, over-the-counter pain relievers, or injections into the knee joint. This trial is testing whether this medication might offer a new option for people whose pain isn't adequately controlled.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you qualify, you'll attend a 7-week screening period where you'll keep a pain diary and have X-rays taken. Then you'll receive twice-weekly injections under your skin for 6 weeks โ either the medication or placebo (you won't know which). You'll continue tracking your pain and attend regular check-in visits. After the 6-week injection period ends, you'll have follow-up visits over the next year so researchers can see how long any pain relief lasts. The entire study lasts up to 64 weeks (about 15 months).
AI-generated summary from trial data ยท Jun 21, 2026 ยท Not medical advice
United States